Development of GS-441524 derivatives as potent SARS-CoV-2 Mac1 inhibitors via a direct-to-biology approach.

GS-441524 - Copycat Sci

http://www.ncbi.nlm.nih.gov/pubmed/42721552

Annette Choi; Gary Whittaker; Hening Lin; J Christopher Fromme; Jéssica Caroline Gomes Noll; Jialin Shang; Kewen Peng; Shamar D Wallace; Suryadeep Chakraborty; Xuan Lu

Sep 11, 2026